Supplier
Oklahoma Cancer and Blood Specialists, LLC
Oklahoma Cancer and Blood Specialists, LLC was paid $942K by Medicaid between Feb 2018 and Nov 2024, across 15 billing codes. Its largest line is J1437, Injection, ferric derisomaltose, 10 mg — 35% of everything it billed.
33Billing provider infoOKLAHOMA CANCER AND BLOOD SPECIALISTS, LLC
OKLAHOMA CITY, OK 73120
OKLAHOMA CITY, OK 73120
33aNPI1831485267assigned 06/23/2011
33bProvider typeNon-Pharmacy Dispensing Site
28Total paid$942K
24GClaims12,163
24DCodes billed15
24AFirst – last monthFeb 2018 – Nov 2024
Compared with peers
Next to other Non-Pharmacy Dispensing Site providers in Oklahoma
Rank by total paid#1 of 5
Median peer was paid$230K
This provider vs. median4.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 286 | $7K | |
| 2019 | 507 | $14K | |
| 2020 | 384 | $11K | |
| 2021 | 693 | $20K | |
| 2022 | 2,352 | $161K | |
| 2023 | 3,800 | $467K | |
| 2024incomplete | 4,141 | $263K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J1437 | Injection, ferric derisomaltose, 10 mg | 35% | 174 | 174 | $330K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 24% | 3,060 | 2,572 | $227K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 20% | 4,054 | 3,632 | $189K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 4.6% | 1,060 | 747 | $43K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 3.8% | 421 | 421 | $36K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 3.3% | 330 | 199 | $31K |
| J1750 | Injection, iron dextran, 50 mg | 3.2% | 95 | 95 | $30K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 2.2% | 177 | 177 | $21K |
| J1756 | Injection, iron sucrose, 1 mg | 2.1% | 450 | 246 | $20K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 1,387 | 1,028 | $8K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 173 | 147 | $4K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 158 | 144 | $4K |
3 more codes
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBORRELL, DENISE (PRACTICE ADMINISTRATOR)